Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Diovan/Co-Diovan

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Diovan/Co-Diovan was produced by Novartis.

It’s only money

It’s only money

It is suspected that falsified data was used in the clinical trial of Novartis’s best selling drug Diovan.

Novartis sales dip, but all eyes are on Entresto

Novartis sales dip, but all eyes are on Entresto pressure drug Diovan (valsartan) and other products such as its oestrogen patch Vivelle-Dot.

Novartis heart drug may see novel pricing plan

Novartis heart drug may see novel pricing plan The drug, which combines its now off patent blood pressure drug Diovan (valsartan) and a new antihypertensive drug sacubitril, is set for approval in August for patients with heart failure.

Heart drug sales continue downward spiral

Heart drug sales continue downward spiral Novartis has been one of the hardest hit in recent years with the patent losses of its blood pressure drug Diovan (valsartan), which was making $6bn in sales a year at

Novartis still hungry after absorbing GSK oncology

Novartis still hungry after absorbing GSK oncology The company is now starting to recover from patent expirations on former top brands such as Diovan (valsartan) for high blood pressure and combination follow-up Exforge (valsartan and amlodipine), with

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Figure 1 Clarivate
The changing nature of approvals – what does the future hold?
The 2019 CMR International Pharmaceutical R&D Factbook...
Spotlight interview: 15 minutes on healthcare communications in gene therapy
Gavin Jones, Director of Rare Disease, OPEN Health takes 15 minutes to answer some key questions on healthcare communications in gene therapy...

Infographics